Suchergebnisse - "SUBKLEWE MARION"

PubPharm (12)

1

CD33 BiTE® molecule-mediated immune synapse formation and subsequent T-cell activation is determined by the expression profile of activating and inhibitory checkpoint molecules on AML cells

enthalten in: Cancer immunology, immunotherapy : CII | 2023

von Marcinek, A. | Brauchle, B. | Rohrbacher, L. | +13

ErratumIn: Cancer Immunol Immunother. 2023 May 8;:. - PMID 37154851

2

CD33 $ BiTE^{®} $ molecule-mediated immune synapse formation and subsequent T-cell activation is determined by the expression profile of activating and inhibitory checkpoint molecules on AML cells

enthalten in: Cancer immunology immunotherapy | 2023

von Marcinek, A. | Brauchle, B. | Rohrbacher, L. | +13

3

CD33 $ BiTE^{®} $ molecule-mediated immune synapse formation and subsequent T-cell activation is determined by the expression profile of activating and inhibitory checkpoint molecules on AML cells

enthalten in: Cancer immunology immunotherapy | 2023

von Marcinek, A. | Brauchle, B. | Rohrbacher, L. | +13

4

CD33 $ BiTE^{®} $ molecule-mediated immune synapse formation and subsequent T-cell activation is determined by the expression profile of activating and inhibitory checkpoint molecules on AML cells

enthalten in: Cancer immunology immunotherapy | 2023

von Marcinek, A. | Brauchle, B. | Rohrbacher, L. | +13

5

Leukemic stem cells as a target for eliminating acute myeloid leukemia : Gaps in translational research

enthalten in: Critical reviews in oncology/hematology | 2022

von Khaldoyanidi, S. | Hindoyan, A. | Stein, A. | +1

6

Integrated multiomic approach for identification of novel immunotherapeutic targets in AML

enthalten in: Biomarker research | 2022

von Köhnke, T. | Liu, X. | Haubner, S. | +6

7

Integrated multiomic approach for identification of novel immunotherapeutic targets in AML

enthalten in: Biomarker Research | 2022

von Köhnke, T. | Liu, X. | Haubner, S. | +6

8

A fluorescence in situ hybridization‐based screen allows rapid detection of adverse cytogenetic alterations in patients with acute myeloid leukemia

enthalten in: Genes, chromosomes & cancer | 2017

von Sandhöfer, N. | Metzeler, K. | Kakadia, P. | +10

9

Impaired NK cells and increased T regulatory cell numbers during cytotoxic maintenance therapy in AML

enthalten in: Leukemia research | 2014

von Lichtenegger, F. | Lorenz, R. | Gellhaus, K. | +3

10

Monoallelic CEBPA mutations in normal karyotype acute myeloid leukemia: independent favorable prognostic factor within NPM1 mutated patients

enthalten in: Annals of hematology | 2012

von Dufour, A. | Schneider, F. | Hoster, E. | +13